Assesment and Comparison of Osteoporosis Risk Factors After Stroke
Recruiting
Observational Study
Stroke Osteoporosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 55 – 85
- Sex
- Any
- Study type
- Observational
- Participants needed
- 84 (estimated)
- Sponsor
- Ankara Etlik City Hospital · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Followed by ischemic or hemorrhagic stroke
2. Between 1 week and 6 months or \>1 year has passed since the date of the event
3. Being between 55 and 85 years of age
Exclusion Criteria:
1. The patient has additional neurological conditions besides stroke
2. The patient has a…
Contacts